Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 1;67(3):316-22.
doi: 10.1097/QAI.0000000000000295.

Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV

Heena Brahmbhatt  1 , Michael Boivin, Victor Ssempijja, Godfrey Kigozi, Joseph Kagaayi, David Serwadda, Ronald H Gray
Affiliations

Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV

Heena Brahmbhatt et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children.

Methods: Prospective study of 329 mothers and children aged 0-6 years to assess neurodevelopment. Results stratified by the maternal (M) and child (C) HIV status (MHIV⁻/CHIV⁻, MHIV⁺/CHIV⁻, and MHIV⁺/CHIV⁺). Gross Motor, Visual Reception, Fine Motor, Receptive, and Expressive Language scores were assessed by Mullen Scales of Early Learning. Global cognitive function was derived from an Early Learning Composite (ELC) score. Standardized weight and height for age z scores were constructed, and the lowest 15% cutoff defined disability. Generalized linear models were used to estimate prevalence rate ratios (PRR) adjusted for the child's age, weight, and height. In HIV-positive children, generalized linear models assessed the impact of ART initiation and duration on neurodevelopment.

Results: Compared with MHIV⁻/CHIV⁻ children, HIV-positive children were more likely to have global deficits in all measures of neurodevelopment except gross motor skills, whereas in MHIV⁺/CHIV⁻ children, there was impairment in receptive language [adjusted PRR = 2.67; confidence interval (CI): 1·08 to 6.60] and the ELC (adjusted PRR = 2.94; CI: 1.11 to 7.82). Of the children born to HIV-positive mothers, HIV-positive children did worse than MHIV⁺/CHIV⁻ only in visual reception skills (adjusted PRR = 2.86; CI: 1.23 to 6.65). Of the 116 HIV-positive children, 44% had initiated ART. Compared with ART duration of <12 months, ART durations of 24-60 months were associated with decreased impairments in Fine Motor, Receptive Language, Expressive Language, and ELC scores.

Conclusions: Longer duration on ART is associated with reduction of some neurologic impairment and early diagnosis and treatment of HIV-positive children is a priority.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Adjusted Early Learning Composite Z-scores for HIV Positive Children, by ART duration
* adjusted for HAZ (Height for Age Z-Score), WAZ (Weight for Age Z-Score), current age and study visit
See this image and copyright information in PMC

References

    1. Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet. 2007;369(9556):145–157. - PubMed
    1. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007;369(9555):60–70. - PMC - PubMed
    1. Engle PL, Black MM, Behrman JR, Cabral de MM, Gertler PJ, Kapiriri L, et al. Strategies to avoid the loss of developmental potential in more than 200 million children in the developing world. Lancet. 2007;369(9557):229–242. - PubMed
    1. IOM. Neurological, psychiatric, and developmental disorders: Meeting the challenge in the developing world. Washington DC: National Academy Press; 2001. - PubMed
    1. Blanchette N, Smith ML, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infection. Brain Cogn. 2001;46(1–2):50–53. - PubMed

Publication types